ArticleOncoTargets and therapy2021

MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.